Trastuzumab-based CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trastuzumab-based CAR-T cells, covering 2025-09-23 to 2025-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors [Phase 1, Phase 2]